Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rfx5
|
ENSMUSG00000005774.6 | Rfx5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Rfx5 | chr3_94953544_94953930 | 338 | 0.752504 | -0.36 | 4.8e-03 | Click! |
Rfx5 | chr3_94950946_94951097 | 3054 | 0.118599 | 0.22 | 8.8e-02 | Click! |
Rfx5 | chr3_94952244_94952395 | 1756 | 0.181244 | 0.21 | 1.1e-01 | Click! |
Rfx5 | chr3_94955690_94955841 | 294 | 0.789418 | 0.15 | 2.4e-01 | Click! |
Rfx5 | chr3_94957052_94957203 | 1656 | 0.187300 | 0.13 | 3.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_72534545_72535249 | 7.15 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
2033 |
0.35 |
chr1_72533122_72533871 | 6.30 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
3434 |
0.27 |
chr8_93814307_93815014 | 5.36 |
4930488L21Rik |
RIKEN cDNA 4930488L21 gene |
938 |
0.54 |
chr9_110054589_110054957 | 4.81 |
Map4 |
microtubule-associated protein 4 |
2721 |
0.19 |
chr1_132541040_132543287 | 4.64 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr8_94998841_94999505 | 4.32 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1708 |
0.25 |
chr3_68573207_68574269 | 4.26 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr2_6881874_6882908 | 4.26 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr4_36953759_36954250 | 4.06 |
Gm12371 |
predicted gene 12371 |
1038 |
0.55 |
chrX_110811626_110812334 | 4.04 |
Gm44593 |
predicted gene 44593 |
344 |
0.89 |
chr8_70119024_70120981 | 3.95 |
Ncan |
neurocan |
871 |
0.35 |
chr2_97471929_97472576 | 3.77 |
Lrrc4c |
leucine rich repeat containing 4C |
4163 |
0.36 |
chr12_89815493_89816199 | 3.77 |
Nrxn3 |
neurexin III |
3363 |
0.39 |
chr1_169746128_169746823 | 3.66 |
Rgs4 |
regulator of G-protein signaling 4 |
1148 |
0.55 |
chr2_155514247_155515194 | 3.56 |
Ggt7 |
gamma-glutamyltransferase 7 |
128 |
0.92 |
chr12_67219520_67219941 | 3.55 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1312 |
0.58 |
chr15_25416075_25416310 | 3.41 |
Gm48957 |
predicted gene, 48957 |
1129 |
0.37 |
chr10_6788358_6789268 | 3.32 |
Oprm1 |
opioid receptor, mu 1 |
4 |
0.99 |
chr9_21196536_21198489 | 3.19 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr5_66678440_66678918 | 3.19 |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
1787 |
0.24 |
chr1_42710531_42711233 | 3.13 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
2572 |
0.21 |
chr7_92234907_92236280 | 3.12 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr3_127661985_127662590 | 3.07 |
Alpk1 |
alpha-kinase 1 |
24053 |
0.1 |
chr11_54598816_54599372 | 3.01 |
Rapgef6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
2920 |
0.29 |
chr9_108785408_108785629 | 3.00 |
Ip6k2 |
inositol hexaphosphate kinase 2 |
1653 |
0.2 |
chr19_19108280_19109261 | 2.91 |
Rorb |
RAR-related orphan receptor beta |
2426 |
0.42 |
chr13_52528621_52529319 | 2.83 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
2309 |
0.41 |
chr7_25068107_25069005 | 2.79 |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
3363 |
0.14 |
chr2_163438209_163439457 | 2.74 |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
300 |
0.84 |
chr14_120388776_120389667 | 2.67 |
Gm26679 |
predicted gene, 26679 |
236 |
0.94 |
chr8_31917541_31918367 | 2.60 |
Nrg1 |
neuregulin 1 |
288 |
0.81 |
chr3_88206822_88208169 | 2.59 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr8_94869714_94871671 | 2.57 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr7_82871690_82872524 | 2.55 |
Mex3b |
mex3 RNA binding family member B |
4774 |
0.17 |
chr5_30712882_30713845 | 2.55 |
Dpysl5 |
dihydropyrimidinase-like 5 |
1462 |
0.33 |
chr8_114911140_114911535 | 2.53 |
Gm22556 |
predicted gene, 22556 |
141576 |
0.05 |
chr5_48598987_48600332 | 2.50 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr11_114793777_114794456 | 2.47 |
Btbd17 |
BTB (POZ) domain containing 17 |
1757 |
0.26 |
chr8_94999966_95000377 | 2.47 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
710 |
0.55 |
chr6_104494741_104495008 | 2.42 |
Cntn6 |
contactin 6 |
1626 |
0.56 |
chr12_59265946_59266170 | 2.38 |
Gm48258 |
predicted gene, 48258 |
3385 |
0.18 |
chr9_58197310_58202560 | 2.36 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr1_89582787_89582938 | 2.30 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
2626 |
0.26 |
chr17_34295833_34296830 | 2.24 |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
8508 |
0.08 |
chr3_79144294_79146166 | 2.21 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr7_99275133_99275418 | 2.21 |
Map6 |
microtubule-associated protein 6 |
6143 |
0.13 |
chr7_45012439_45013818 | 2.20 |
Scaf1 |
SR-related CTD-associated factor 1 |
433 |
0.44 |
chr1_66323360_66324079 | 2.20 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr13_109119573_109119724 | 2.20 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
3007 |
0.42 |
chr18_83192582_83193531 | 2.19 |
1700095A13Rik |
RIKEN cDNA 1700095A13 gene |
85166 |
0.08 |
chr2_180895307_180895458 | 2.17 |
Gm27032 |
predicted gene, 27032 |
1277 |
0.23 |
chr16_21846848_21847588 | 2.17 |
Gm26744 |
predicted gene, 26744 |
1442 |
0.29 |
chr6_16999534_17000213 | 2.16 |
Gm15473 |
predicted gene 15473 |
65123 |
0.1 |
chr3_38480746_38481166 | 2.14 |
Ankrd50 |
ankyrin repeat domain 50 |
2135 |
0.29 |
chr7_28464120_28465208 | 2.10 |
Lrfn1 |
leucine rich repeat and fibronectin type III domain containing 1 |
6006 |
0.09 |
chr4_156182317_156182745 | 2.09 |
Agrn |
agrin |
3370 |
0.13 |
chr7_78885666_78887958 | 2.05 |
Mir7-2 |
microRNA 7-2 |
1465 |
0.28 |
chr1_42472502_42472957 | 2.04 |
Gm37047 |
predicted gene, 37047 |
19084 |
0.24 |
chr2_105668422_105670370 | 2.00 |
Pax6 |
paired box 6 |
461 |
0.65 |
chr1_42698766_42699058 | 1.99 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
3144 |
0.17 |
chr4_5724213_5725550 | 1.98 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr16_37938395_37939150 | 1.98 |
Gpr156 |
G protein-coupled receptor 156 |
22276 |
0.15 |
chr6_38251432_38251939 | 1.95 |
D630045J12Rik |
RIKEN cDNA D630045J12 gene |
2270 |
0.28 |
chr1_160351861_160352416 | 1.95 |
Rabgap1l |
RAB GTPase activating protein 1-like |
567 |
0.73 |
chr7_29303732_29303883 | 1.91 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
144 |
0.92 |
chr16_97167039_97167850 | 1.90 |
Dscam |
DS cell adhesion molecule |
3308 |
0.37 |
chr7_54835204_54836499 | 1.88 |
Luzp2 |
leucine zipper protein 2 |
236 |
0.94 |
chr12_66470263_66470830 | 1.84 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
512 |
0.76 |
chr18_37217058_37218378 | 1.84 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chr1_25033558_25033927 | 1.84 |
Gm29414 |
predicted gene 29414 |
6510 |
0.21 |
chr8_83167665_83167943 | 1.84 |
Gm10645 |
predicted gene 10645 |
1634 |
0.32 |
chr10_123266263_123266414 | 1.82 |
Tafa2 |
TAFA chemokine like family member 2 |
1353 |
0.48 |
chr13_54745986_54746481 | 1.82 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
3436 |
0.15 |
chr7_78882466_78883900 | 1.82 |
Mir7-2 |
microRNA 7-2 |
5094 |
0.13 |
chr3_88218645_88218828 | 1.80 |
Gm25641 |
predicted gene, 25641 |
3040 |
0.1 |
chr8_94869021_94869682 | 1.80 |
Dok4 |
docking protein 4 |
1853 |
0.2 |
chr18_42898303_42899688 | 1.76 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
180 |
0.96 |
chr9_51766782_51767242 | 1.76 |
Arhgap20 |
Rho GTPase activating protein 20 |
1352 |
0.52 |
chr7_49914124_49915124 | 1.76 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
2924 |
0.34 |
chr9_45432313_45432910 | 1.73 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
881 |
0.47 |
chr18_23035786_23035937 | 1.72 |
Nol4 |
nucleolar protein 4 |
2795 |
0.4 |
chr9_91409233_91410203 | 1.71 |
Gm29478 |
predicted gene 29478 |
5244 |
0.16 |
chr14_76420544_76421824 | 1.71 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr10_34316245_34317506 | 1.70 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
3192 |
0.16 |
chr1_193369065_193370282 | 1.68 |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
552 |
0.7 |
chr13_97245763_97246942 | 1.67 |
Enc1 |
ectodermal-neural cortex 1 |
5247 |
0.18 |
chr14_100374663_100375528 | 1.67 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr4_32241680_32242499 | 1.66 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
3012 |
0.26 |
chr8_83898627_83899040 | 1.65 |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
1272 |
0.32 |
chr11_101469942_101470777 | 1.63 |
Rnd2 |
Rho family GTPase 2 |
2184 |
0.12 |
chr8_48839540_48839691 | 1.62 |
Gm19744 |
predicted gene, 19744 |
4050 |
0.26 |
chr5_43239013_43240191 | 1.60 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
2287 |
0.23 |
chr1_42691569_42692627 | 1.59 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr18_86711078_86712342 | 1.59 |
Cbln2 |
cerebellin 2 precursor protein |
190 |
0.97 |
chr19_6501834_6503156 | 1.57 |
Nrxn2 |
neurexin II |
4660 |
0.14 |
chr2_152085191_152085589 | 1.57 |
Scrt2 |
scratch family zinc finger 2 |
3861 |
0.17 |
chr7_134774478_134774851 | 1.54 |
Dock1 |
dedicator of cytokinesis 1 |
2791 |
0.37 |
chr7_46399032_46399239 | 1.52 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
1487 |
0.35 |
chr18_77562763_77562968 | 1.51 |
Rnf165 |
ring finger protein 165 |
1744 |
0.41 |
chr2_25264308_25268001 | 1.50 |
Tprn |
taperin |
1410 |
0.14 |
chr2_55436043_55436650 | 1.49 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
376 |
0.9 |
chr10_69705909_69707430 | 1.49 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr6_28829740_28830660 | 1.48 |
Lrrc4 |
leucine rich repeat containing 4 |
145 |
0.96 |
chr6_63255682_63256964 | 1.48 |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
128 |
0.93 |
chr7_46638326_46638538 | 1.45 |
Sergef |
secretion regulating guanine nucleotide exchange factor |
1148 |
0.38 |
chr7_57509014_57510202 | 1.44 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
237 |
0.95 |
chr6_63259715_63260577 | 1.42 |
9330118I20Rik |
RIKEN cDNA 9330118I20 gene |
2521 |
0.27 |
chr2_116045038_116045398 | 1.41 |
Meis2 |
Meis homeobox 2 |
3172 |
0.24 |
chr2_152081612_152083149 | 1.41 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr11_46309925_46310526 | 1.40 |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
1995 |
0.28 |
chr4_41858405_41858994 | 1.39 |
Gm13302 |
predicted gene 13302 |
34689 |
0.09 |
chr4_13773806_13774269 | 1.39 |
Runx1t1 |
RUNX1 translocation partner 1 |
2660 |
0.41 |
chr5_123891701_123891876 | 1.38 |
Hcar1 |
hydrocarboxylic acid receptor 1 |
11768 |
0.11 |
chr8_109250884_109251908 | 1.38 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr14_104464182_104464605 | 1.37 |
Pou4f1 |
POU domain, class 4, transcription factor 1 |
972 |
0.53 |
chr17_23733537_23733688 | 1.36 |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
1115 |
0.21 |
chr4_42207648_42208229 | 1.36 |
Gm17167 |
predicted gene 17167 |
940 |
0.32 |
chr11_69413887_69414228 | 1.36 |
Kdm6b |
KDM1 lysine (K)-specific demethylase 6B |
382 |
0.7 |
chr10_78470826_78471253 | 1.35 |
4933436P19Rik |
RIKEN cDNA 4933436P19 gene |
217 |
0.83 |
chr14_68123421_68125146 | 1.35 |
Nefm |
neurofilament, medium polypeptide |
563 |
0.74 |
chr1_177640551_177640938 | 1.35 |
2310043L19Rik |
RIKEN cDNA 2310043L19 gene |
2199 |
0.28 |
chr16_94236634_94237017 | 1.34 |
Gm6363 |
predicted gene 6363 |
6522 |
0.14 |
chrX_136994200_136994351 | 1.33 |
Zcchc18 |
zinc finger, CCHC domain containing 18 |
977 |
0.28 |
chr15_92160888_92162023 | 1.33 |
Cntn1 |
contactin 1 |
98 |
0.98 |
chr8_90958160_90958505 | 1.33 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
2897 |
0.24 |
chr6_108708998_108710182 | 1.33 |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
46544 |
0.12 |
chr1_131522570_131523013 | 1.32 |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
4556 |
0.17 |
chr7_126827040_126827191 | 1.31 |
Fam57b |
family with sequence similarity 57, member B |
2462 |
0.09 |
chr6_92705064_92706537 | 1.30 |
Prickle2 |
prickle planar cell polarity protein 2 |
355 |
0.92 |
chr1_5916517_5917959 | 1.29 |
Npbwr1 |
neuropeptides B/W receptor 1 |
160 |
0.97 |
chr7_144896076_144897460 | 1.29 |
Fgf15 |
fibroblast growth factor 15 |
204 |
0.8 |
chr11_3370456_3371381 | 1.28 |
Limk2 |
LIM motif-containing protein kinase 2 |
417 |
0.76 |
chr18_72350573_72351222 | 1.28 |
Dcc |
deleted in colorectal carcinoma |
120 |
0.98 |
chr4_150651111_150652374 | 1.27 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr8_117259289_117259783 | 1.26 |
Cmip |
c-Maf inducing protein |
2419 |
0.37 |
chr2_25318080_25319601 | 1.26 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr5_37245879_37246957 | 1.24 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr3_88208985_88210116 | 1.24 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr7_125580853_125581714 | 1.23 |
Gm44876 |
predicted gene 44876 |
9166 |
0.16 |
chr15_98983254_98984205 | 1.23 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr4_42704986_42705399 | 1.23 |
Gm21955 |
predicted gene, 21955 |
9734 |
0.12 |
chr1_158364281_158364968 | 1.23 |
Astn1 |
astrotactin 1 |
2074 |
0.31 |
chr8_69182123_69182365 | 1.23 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
14 |
0.97 |
chr3_84953332_84953942 | 1.21 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
1491 |
0.53 |
chr5_103209022_103210413 | 1.21 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr13_52528312_52528571 | 1.21 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
2838 |
0.37 |
chr4_42476330_42476661 | 1.21 |
Gm2163 |
predicted gene 2163 |
9523 |
0.14 |
chr4_42369833_42370169 | 1.20 |
Fam205a3 |
family with sequence similarity 205, member A3 |
51729 |
0.08 |
chr1_34679747_34679898 | 1.20 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
1634 |
0.3 |
chr6_95202423_95203490 | 1.19 |
Gm17822 |
predicted gene, 17822 |
37622 |
0.15 |
chr8_47284401_47285223 | 1.19 |
Stox2 |
storkhead box 2 |
4550 |
0.27 |
chr4_45823361_45823707 | 1.19 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
3389 |
0.19 |
chr9_41011710_41012005 | 1.18 |
Crtam |
cytotoxic and regulatory T cell molecule |
7229 |
0.19 |
chr4_42804643_42804969 | 1.18 |
Ccl21a |
chemokine (C-C motif) ligand 21A (serine) |
30813 |
0.1 |
chr19_44295047_44295933 | 1.17 |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
1414 |
0.27 |
chr9_57468140_57468355 | 1.16 |
Scamp5 |
secretory carrier membrane protein 5 |
187 |
0.89 |
chr17_34398538_34399000 | 1.15 |
BC051142 |
cDNA sequence BC051142 |
51 |
0.89 |
chr2_11499223_11499403 | 1.15 |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
928 |
0.5 |
chr8_12947702_12949640 | 1.14 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr13_97245078_97245388 | 1.14 |
Enc1 |
ectodermal-neural cortex 1 |
4128 |
0.2 |
chrX_152366181_152366965 | 1.13 |
3010001F23Rik |
RIKEN cDNA 3010001F23 gene |
2000 |
0.23 |
chr13_83662978_83663196 | 1.13 |
Mef2c |
myocyte enhancer factor 2C |
10199 |
0.18 |
chr3_89243498_89245184 | 1.13 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr9_41588484_41589112 | 1.13 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
304 |
0.82 |
chr14_93889405_93889684 | 1.12 |
Pcdh9 |
protocadherin 9 |
615 |
0.83 |
chr9_43969827_43970154 | 1.10 |
Gm30373 |
predicted gene, 30373 |
181 |
0.91 |
chr14_64589664_64590503 | 1.10 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
388 |
0.55 |
chr9_58206018_58206268 | 1.10 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
1824 |
0.17 |
chr11_25854310_25854556 | 1.09 |
5730522E02Rik |
RIKEN cDNA 5730522E02 gene |
85292 |
0.11 |
chr11_102227930_102228817 | 1.08 |
Hdac5 |
histone deacetylase 5 |
1751 |
0.18 |
chr4_42017529_42017915 | 1.08 |
Gm13303 |
predicted gene 13303 |
9180 |
0.1 |
chr15_59319527_59320112 | 1.08 |
Sqle |
squalene epoxidase |
4712 |
0.18 |
chr8_84179852_84181199 | 1.08 |
Mir181c |
microRNA 181c |
1564 |
0.13 |
chr1_93100315_93101980 | 1.07 |
Kif1a |
kinesin family member 1A |
675 |
0.62 |
chr9_37145312_37146292 | 1.07 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
13 |
0.96 |
chr4_121230932_121231762 | 1.06 |
Gm12890 |
predicted gene 12890 |
3874 |
0.2 |
chr12_107996863_107997549 | 1.06 |
Bcl11b |
B cell leukemia/lymphoma 11B |
6208 |
0.3 |
chrX_146961528_146961745 | 1.06 |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
877 |
0.52 |
chr8_105289012_105289189 | 1.06 |
4931428F04Rik |
RIKEN cDNA 4931428F04 gene |
22 |
0.87 |
chr14_66635276_66637386 | 1.05 |
Adra1a |
adrenergic receptor, alpha 1a |
775 |
0.72 |
chr8_58908783_58909433 | 1.03 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
2468 |
0.31 |
chr9_31082148_31082491 | 1.03 |
Gm17508 |
predicted gene, 17508 |
156 |
0.94 |
chr10_86497964_86499185 | 1.02 |
Syn3 |
synapsin III |
282 |
0.85 |
chr14_11556261_11556718 | 1.02 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
2908 |
0.29 |
chr4_110282527_110283235 | 1.02 |
Elavl4 |
ELAV like RNA binding protein 4 |
3735 |
0.36 |
chr4_128886354_128886923 | 1.01 |
Trim62 |
tripartite motif-containing 62 |
3050 |
0.2 |
chr19_5509775_5510003 | 1.00 |
Snx32 |
sorting nexin 32 |
574 |
0.45 |
chr13_94879818_94880134 | 0.99 |
Otp |
orthopedia homeobox |
2624 |
0.29 |
chr7_65955296_65955788 | 0.99 |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
2530 |
0.31 |
chr10_73099097_73100287 | 0.99 |
Pcdh15 |
protocadherin 15 |
239 |
0.94 |
chr8_45508499_45509041 | 0.98 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr6_8949544_8950237 | 0.98 |
Nxph1 |
neurexophilin 1 |
214 |
0.97 |
chr9_62809372_62809735 | 0.97 |
Fem1b |
fem 1 homolog b |
2381 |
0.22 |
chr3_13472761_13473581 | 0.96 |
Ralyl |
RALY RNA binding protein-like |
49 |
0.97 |
chr2_70202056_70202377 | 0.96 |
Myo3b |
myosin IIIB |
105918 |
0.06 |
chr6_148046801_148048056 | 0.96 |
Far2 |
fatty acyl CoA reductase 2 |
12 |
0.57 |
chr10_29142553_29142958 | 0.96 |
Soga3 |
SOGA family member 3 |
1084 |
0.4 |
chr17_48970558_48970709 | 0.95 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
38254 |
0.19 |
chr12_81777919_81778812 | 0.95 |
Map3k9 |
mitogen-activated protein kinase kinase kinase 9 |
2509 |
0.24 |
chr13_15802510_15802690 | 0.95 |
4933412O06Rik |
RIKEN cDNA 4933412O06 gene |
30 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.0 | 3.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.7 | 2.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.7 | 2.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.5 | 2.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 1.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.4 | 1.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 1.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.4 | 1.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 2.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 1.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.0 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 1.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 1.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 1.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 1.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 2.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 3.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.8 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 2.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 1.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 1.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 1.4 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.6 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.7 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 1.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.9 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 1.7 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.0 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.3 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 2.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.1 | 0.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.4 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.1 | 0.3 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.4 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 1.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 1.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 3.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 1.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 1.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 1.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.1 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.4 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.3 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.2 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.4 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 2.1 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 1.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.0 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 1.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 2.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.4 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.4 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.7 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 1.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.0 | 0.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0070666 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 2.1 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.4 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 1.8 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.2 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.0 | 0.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.9 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.0 | 0.0 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.4 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.0 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.0 | 0.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.0 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.1 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 5.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 2.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 5.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.6 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 2.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 4.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 3.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 2.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.8 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 1.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 2.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 4.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 3.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 2.3 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 2.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 1.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 1.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.0 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 1.0 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.0 | 0.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.0 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0001650 | fibrillar center(GO:0001650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 3.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 3.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 2.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 2.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 0.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 0.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 4.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 1.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 1.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0034927 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.1 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 3.7 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 1.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 3.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.3 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 1.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 3.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.0 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.7 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.5 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 3.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 2.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 2.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 3.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 5.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.0 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |